By Jenny Bryan2000-11-30T00:00:00
The huge rise in the type-2 diabetes population - and the introduction of major new drug treatments - is set to pose some increasingly tough management decisions, writes Jenny Bryan
With a HSJ subscription you’ll unlock:
HSJ is part of Wilmington Healthcare Limited. Company number 2530185. c/o Wilmington plc, 5th Floor, 10 Whitechapel High Street, London E1 8QS. Registered in England and Wales. Company registration 30158470
Site powered by Webvision Cloud